Novavax (NVAX) Tops Q4 EPS by 60c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.14 --0%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of $0.11, $0.60 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $147 million versus the consensus estimate of $90.25 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- BMO Capital Reiterates Outperform Rating on Netflix (NFLX), Advertising Seen As a Key Lever
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
